Please log in to access this page.

Sumatriptan and Nifedipine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan (sumatriptan succinate) and Nifedipine (nifedipine). Common drug interactions include gastrointestinal disorder among females and neuropathy peripheral among males.

The phase IV clinical study analyzes what interactions people have when they take Sumatriptan and Nifedipine. It is created by eHealthMe based on reports of 72 people who take the same drugs from the FDA, and is updated regularly.

What is Sumatriptan?

Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 18,159 Sumatriptan users. Check the latest studies of Sumatriptan.

What is Nifedipine?

Nifedipine has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 53,459 Nifedipine users. Check the latest studies of Nifedipine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Jul, 03, 2026

72 people who take Sumatriptan and Nifedipine together, and have interactions are studied.

Sumatriptan and Nifedipine drug interactions.

What are the common drug interactions of Sumatriptan and Nifedipine, by gender? *:

female:

  1. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  2. Haemangioma of liver (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in liver)
  3. Infective spondylitis (infective inflammation of a spinal joint; characterized by pain and stiffness)
  4. Lumbosacral plexus injury (injury to lumbosacral nerve branching network)
  5. Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
  6. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  7. Nephrolithiasis (calculi in the kidneys)
  8. Osteomyelitis (infection of bone)
  9. Osteoporosis (bones weak and more likely to break)
  10. Post procedural complication

male:

  1. Neuropathy peripheral (surface nerve damage)
  2. Weight fluctuation
  3. Nephrolithiasis (calculi in the kidneys)
  4. Oedema peripheral (superficial swelling)
  5. Tachypnoea (a condition of rapid breathing over 20 per minute)
  6. Chronic kidney disease
  7. Drug exposure during pregnancy
  8. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Premature labour

What are the common drug interactions of Sumatriptan and Nifedipine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Behcet's syndrome (involves inflammation of the blood vessels)
  2. Drug hypersensitivity
  3. Nausea (feeling of having an urge to vomit)
  4. Pain
  5. Pancreatitis acute (sudden inflammation of pancreas)
  6. Vomiting
  7. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  8. Weight fluctuation
  9. Abdominal infection
  10. Chronic kidney disease

40-49:

  1. Abdominal discomfort
  2. Cluster headache (one-sided head pain with tearing)
  3. Acne (skin problems that cause pimples)
  4. Bladder disorder
  5. Breast cancer
  6. Dehydration (dryness resulting from the removal of water)
  7. Depression
  8. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  9. Headache (pain in head)
  10. Infective spondylitis (infective inflammation of a spinal joint; characterized by pain and stiffness)

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal tubular necrosis (death of kidney tubules)
  4. Anuria (failure of the kidneys to produce urine)
  5. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  6. Blood iron decreased
  7. Crest syndrome (thick, dry and fibrous skin)
  8. Headache (pain in head)
  9. Kidney transplant rejection
  10. Malignant melanoma (skin cancer rises from melancytes)

60+:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Decreased appetite
  4. Drug ineffective
  5. Dyspnoea (difficult or laboured respiration)
  6. Epistaxis (bleed from the nose)
  7. Generalised oedema (swelling all over the body)
  8. Headache (pain in head)
  9. Heart rate increased
  10. Hypersensitivity

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 24 people, 33.33%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 24 people, 33.33%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 11.11%
  4. Infection: 7 people, 9.72%
  5. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 5.56%
  6. Ill-Defined Disorder: 4 people, 5.56%
  7. Headache (pain in head): 4 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan and Nifedipine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sumatriptan and Nifedipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sumatriptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nifedipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sumatriptan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nifedipine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate and nifedipine (the active ingredients of Sumatriptan and Nifedipine, respectively), and Sumatriptan and Nifedipine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: